🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
An Open-Label, Long-Term Follow Up Study of Safety and Efficacy in PKU Subj...
Status
Enrolling By Invitation
Location
Boston Children's Hospital
Start Date
2020-08-19
Trial ID
NCT04348708
Treatments Being Tested
The scaling up of Long Lasting Insecticidal Nets (LLIN) and the expansion o...
Status
Completed
Location
Multiple Locations
Start Date
2012-05
Trial ID
NCT01663831
Treatments Being Tested
The purpose of this trial is to evaluate safety and efficacy of intrathecal...
Status
Enrolling By Invitation
Location
Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine
Start Date
2025-03-10
Trial ID
NCT06888661
Treatments Being Tested
This trial employs a multicenter, randomized, open-label, standard-of-care-...
Status
Recruiting
Location
The Seventh Medical Center of Chinese PLA General Hospital
Start Date
2025-05-27
Trial ID
NCT06971094
Treatments Being Tested
Nasal continuous positive airway pressure (CPAP) and Nasal High Flow (NHF) ...
Status
Unknown
Location
Erebouni Medical Centre, NICU
Start Date
2021-09-06
Trial ID
NCT05036161
Treatments Being Tested
In this prospective study, new diagnostic tools will be explored for patien...
Status
Recruiting
Location
Ghent University Hospital
Start Date
2022-12-12
Trial ID
NCT05298722
This stepped-wedge cluster-randomized controlled trial with nested mixed me...
Status
Unknown
Location
Multiple Locations
Start Date
2022-01-01
Trial ID
NCT05025761
Treatments Being Tested
LYS-GM101 is a gene therapy for GM1 gangliosidosis intended to deliver a fu...
Status
Terminated
Location
Children's Hospital of Orange County (CHOC)
Start Date
2021-05-11
Trial ID
NCT04273269
Treatments Being Tested
An evaluation of LY007 cell injection for recurrent/refractory CD20 was pos...
Status
Unknown
Location
Ruijin hospital
Start Date
2021-12-25
Trial ID
NCT06364852
Treatments Being Tested
The primary purpose of this trial is to determine the safety of XC001 (AdVE...
Status
Completed
Location
Stanford University
Start Date
2020-01-24
Trial ID
NCT04125732
Treatments Being Tested